Annual Report Kimia Farma 2012: A Look Back

Annual Report Kimia Farma 2010 (Low Quality For Email) PDF Business
Annual Report Kimia Farma 2010 (Low Quality For Email) PDF Business from www.scribd.com

Introduction

What is Kimia Farma?

Kimia Farma is a pharmaceutical company that was founded in 1817 in Indonesia. The company has been providing quality pharmaceutical products and services for over 200 years.

The Importance of Annual Reports

Annual reports are important documents that companies produce every year to provide information about their financial performance and activities throughout the year. These reports are used by stakeholders to evaluate the company’s performance and make informed decisions.

Kimia Farma’s Annual Report 2012

Kimia Farma’s annual report for 2012 provides a comprehensive overview of the company’s financial performance and activities during the year. The report includes information about the company’s revenue, expenses, assets, liabilities, and profits.

Revenue

In 2012, Kimia Farma’s revenue was IDR 5.7 trillion, which was a 15% increase from the previous year. This increase was attributed to the company’s strong sales performance in both its pharmaceutical and non-pharmaceutical businesses.

Expenses

The company’s expenses in 2012 were IDR 4.9 trillion, which was a 16% increase from the previous year. This increase was primarily due to the company’s investment in expanding its operations and improving its infrastructure.

Assets and Liabilities

As of December 31, 2012, Kimia Farma’s total assets were valued at IDR 7.2 trillion, while its total liabilities were valued at IDR 4.1 trillion. This resulted in a net asset value of IDR 3.1 trillion, which was a 19% increase from the previous year.

Profits

Kimia Farma’s net profit in 2012 was IDR 654 billion, which was a 7% increase from the previous year. This increase was attributed to the company’s strong sales performance and cost management efforts.

Conclusion

Overall, Kimia Farma’s annual report for 2012 shows that the company had a strong financial performance and made significant progress in expanding its operations and improving its infrastructure. The report also highlights the importance of annual reports in evaluating a company’s performance and making informed decisions.

As a leading pharmaceutical company in Indonesia, Kimia Farma’s commitment to providing quality products and services has helped it to maintain its position as a trusted and reliable provider of healthcare solutions. We look forward to seeing what the future holds for Kimia Farma and its continued success in the years to come.